US 9765338
Modulation of dystrophia myotonica-protein kinase (DMPK) expression
granted A61PA61P15/00A61P21/00
Quick answer
US patent 9765338 (Modulation of dystrophia myotonica-protein kinase (DMPK) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P15/00, A61P21/00, A61P21/04, A61P25/14